Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!

Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.

Leigh Vosseller Biography and Net Worth

CFO of Tandem Diabetes Care

Leigh Vosseller has served as our Executive Vice President, Chief Financial Officer and Treasurer since June 2018, and served as Senior Vice President, Chief Financial Officer and Treasurer from January 2018 to May 2018. Ms. Vosseller is our principal financial and accounting officer. She joined us as Vice President of Finance in 2013 and was promoted to Senior Vice President of Finance in August 2017. Prior to that time, she served as Vice President and Chief Financial Officer at Genoptix, beginning in 2011, after initially joining Genoptix in 2008. Prior to that she held a senior finance position at Biosite where she played a key role in developing the financial and administrative infrastructure for international expansion. Ms. Vosseller is a certified public accountant (inactive) and holds a BS in Accounting from Missouri State University.

What is Leigh Vosseller's net worth?: The estimated net worth of Leigh Vosseller is at least $414,507.00 as of November 8th, 2023. Ms. Vosseller owns 11,860 shares of Tandem Diabetes Care stock worth more than $414,507 as of April 26th. This net worth evaluation does not reflect any other assets that Ms. Vosseller may own. Additionally, Ms. Vosseller receives a salary of $543,380.00 as CFO at Tandem Diabetes Care. Learn More about Leigh Vosseller's net worth.
How old is Leigh Vosseller?: Ms. Vosseller is currently 50 years old. There are 8 older executives and no younger executives at Tandem Diabetes Care. The oldest executive at Tandem Diabetes Care is Mr. John F. Sheridan, President, CEO & Director, who is 69 years old. Learn More on Leigh Vosseller's age.
What is Leigh Vosseller's salary?: As the CFO of Tandem Diabetes Care, Inc., Ms. Vosseller earns $543,380.00 per year. There are 2 executives that earn more than Ms. Vosseller. The highest earning executive at Tandem Diabetes Care is Mr. John F. Sheridan, President, CEO & Director, who commands a salary of $988,350.00 per year. Learn More on Leigh Vosseller's salary.
How do I contact Leigh Vosseller?: The corporate mailing address for Ms. Vosseller and other Tandem Diabetes Care executives is 11075 ROSELLE STREET, San Diego CA, 92121. Tandem Diabetes Care can also be reached via phone at (858) 366-6900 and via email at [email protected]. Learn More on Leigh Vosseller's contact information.
Has Leigh Vosseller been buying or selling shares of Tandem Diabetes Care?: Leigh Vosseller has not been actively trading shares of Tandem Diabetes Care in the last ninety days. Most recently, on Wednesday, November 8th, Leigh Vosseller bought 6,200 shares of Tandem Diabetes Care stock. The stock was acquired at an average cost of $15.39 per share, with a total value of $95,418.00. Following the completion of the transaction, the chief financial officer now directly owns 11,860 shares of the company's stock, valued at $182,525.40. Learn More on Leigh Vosseller's trading history.
Who are Tandem Diabetes Care's active insiders?: Tandem Diabetes Care's insider roster includes David Berger (EVP), Kim Blickenstaff (Director), Elizabeth Gasser (EVP), Brian Hansen (EVP), James Leal (SVP), Kathleen McGroddy-Goetz (Director), Susan Morrison (EVP), Rebecca Robertson (Director), John Sheridan (CEO), Christopher Twomey (Director), and Leigh Vosseller (CFO). Learn More on Tandem Diabetes Care's active insiders.
Are insiders buying or selling shares of Tandem Diabetes Care?: In the last twelve months, Tandem Diabetes Care insiders bought shares 6 times. They purchased a total of 27,150 shares worth more than $635,045.95. The most recent insider tranaction occured on November, 27th when Director Dick Allen bought 5,000 shares worth more than $94,800.00. Insiders at Tandem Diabetes Care own 2.5% of the company. Learn More about insider trades at Tandem Diabetes Care.
Information on this page was last updated on 11/27/2023.

Leigh Vosseller Insider Trading History at Tandem Diabetes Care

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/8/2023	Buy	6,200	$15.39	$95,418.00	11,860
5/12/2023	Buy	3,015	$32.77	$98,801.55	5,660
5/9/2022	Buy	500	$70.00	$35,000.00	9,118
5/6/2022	Buy	2,000	$75.76	$151,520.00	8,618
11/3/2021	Sell	10,000	$140.05	$1,400,500.00
10/14/2021	Sell	10,000	$135.09	$1,350,900.00
10/12/2021	Sell	10,000	$130.00	$1,300,000.00
9/15/2021	Sell	3,500	$125.00	$437,500.00
9/13/2021	Sell	10,000	$120.75	$1,207,500.00	16,145
10/13/2020	Sell	10,000	$120.87	$1,208,700.00	14,520
7/31/2020	Sell	10,000	$110.03	$1,100,300.00	14,520
7/6/2020	Sell	10,000	$105.04	$1,050,400.00	14,520
7/2/2020	Sell	20,000	$97.74	$1,954,800.00	14,520
6/30/2020	Sell	10,000	$95.04	$950,400.00	14,520
5/7/2020	Sell	10,000	$90.07	$900,700.00	13,265
1/29/2020	Sell	10,000	$75.93	$759,300.00	12,882
11/25/2019	Sell	10,000	$70.35	$703,500.00	13,265
11/18/2019	Sell	10,000	$65.41	$654,100.00	13,265
5/16/2019	Sell	10,000	$70.45	$704,500.00	12,009
5/3/2019	Sell	10,000	$65.14	$651,400.00	12,009

Leigh Vosseller Buying and Selling Activity at Tandem Diabetes Care

Tandem Diabetes Care Company Overview

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Today's Range

Now: $34.95

$34.77

$35.82

50 Day Range

MA: $30.74

$22.55

$35.56

2 Week Range

Now: $34.95

$13.82

$40.74

Volume

137,363 shs

Average Volume

1,713,380 shs

Market Capitalization

$2.26 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.12

Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!

From Priority Gold | Ad

Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.

Click here for your free guide

Leigh Vosseller Biography and Net Worth

What is Leigh Vosseller's net worth?

How old is Leigh Vosseller?

What is Leigh Vosseller's salary?

How do I contact Leigh Vosseller?

Has Leigh Vosseller been buying or selling shares of Tandem Diabetes Care?

Who are Tandem Diabetes Care's active insiders?

Are insiders buying or selling shares of Tandem Diabetes Care?